Pomalidomide(CAS: 19171-19-8)

Pomalidomide is a derivative of thalidomide, with the chemical formula C14H16N2O2. It is a white to off-white crystalline powder, known for its low solubility in water and high solubility in organic solvents. Pomalidomide exhibits immunomodulatory and anti-angiogenic properties, making it a valuable compound in pharmaceutical research.

Pomalidomide is primarily used in the treatment of multiple myeloma, particularly in patients who have relapsed or are refractory to other therapies. It is also utilized in research for its potential applications in immunotherapy and as an anti-cancer agent. The compound's unique properties make it relevant in both clinical and experimental settings.

Pomalidomide is generally considered safe when used under medical supervision, but it requires careful handling due to potential side effects such as peripheral neuropathy and teratogenicity. Proper safety protocols, including protective clothing and controlled environments, should be followed to minimize risks and ensure compliance with regulatory standards.

Pomalidomide should be stored in a cool, dry, and dark place, ideally at 2-8°C. It is sensitive to moisture and light, so it should be kept in a sealed, light-resistant container. Maintaining proper storage conditions ensures its stability and prolongs its shelf life for both research and pharmaceutical use.